Some Weight-Loss Drugs Are More Effective Than Others

This article originally appeared here.
Share this content:
Some Weight-Loss Drugs Are More Effective Than Others
Some Weight-Loss Drugs Are More Effective Than Others

TUESDAY, June 14, 2016 (HealthDay News) -- Any of the prescription weight-loss drugs on the market can help obese adults lose weight, although some appear to be more effective than others, according to research published in the June 14 issue of the Journal of the American Medical Association.

Siddharth Singh, M.D., assistant clinical professor at the University of California, San Diego, and colleagues analyzed findings from 28 clinical trials testing the five approved drugs for obesity: phentermine-topiramate (Qsymia), liraglutide (Victoza) and orlistat (Xenical), along with lorcaserin (Belviq) and naltrexone-bupropion (Contrave).

On average, the researchers found, each drug worked better than a placebo in helping obese adults lose weight over a year. Patients on phentermine-topiramate typically lost the most weight (8.8 kg) versus study patients taking placebo. Patients taking orlistat or lorcaserin tended to lose the least amount (2.6 and 3.2 kg, respectively) versus placebo users. Naltrexone-bupropion and liraglutide patients typically lost 5.0 and 5.3 kg more, compared with placebo. Patients taking naltrexone-bupropion or liraglutide were the most likely to quit a trial over side effects, compared with placebo users (odds ratios, 2.64 and 2.95, respectively).

"Among overweight or obese adults, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide, compared with placebo, were each associated with achieving at least 5 percent weight loss at 52 weeks," the authors conclude.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Caffeine Found to Reduce Age-Related Inflammation

Caffeine Found to Reduce Age-Related Inflammation

Connection between advancing age, systemic inflammation, cardiovascular disease and caffeine

Neonatal Abstinence Syndrome Tied to Poor School Performance

Neonatal Abstinence Syndrome Tied to Poor School Performance

By seventh grade, four out of 10 failed to meet standards in at least one academic area

Heart Rate Variability Linked to Atrial Fibrillation

Heart Rate Variability Linked to Atrial Fibrillation

Lower HRV, increased sympathetic/parasympathetic tone linked to higher risk of a-fib

is free, fast, and customized just for you!

Already a member?

Sign In Now »